All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

The impact of changes in national prescribing conditions for statins on their public expenditure and utilization in the Czech Republic 1997-2013

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11160%2F15%3A10312610" target="_blank" >RIV/00216208:11160/15:10312610 - isvavai.cz</a>

  • Result on the web

    <a href="http://www.sciencedirect.com/science/article/pii/S0168851015000676" target="_blank" >http://www.sciencedirect.com/science/article/pii/S0168851015000676</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.healthpol.2015.02.016" target="_blank" >10.1016/j.healthpol.2015.02.016</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    The impact of changes in national prescribing conditions for statins on their public expenditure and utilization in the Czech Republic 1997-2013

  • Original language description

    Objectives: In the Czech Republic (CZ) extensive price regulation and prescribing conditions are common instruments often employed with new drugs. Since the introduction of statins onto the market in 1990s the originally strict conditions gradually relaxed while the prescription rates and public costs were rising. The aim was to analyze long-term utilization trends of statins, changes in their reimbursement prices and prescribing conditions, and the evolution of the market. Methods: From January 1997 toDecember 2013 statin use was measured in terms of defined daily doses per 1000 insured per day (DDD/TID). The prescription-based database of the General Health Insurance Company of the Czech Republic in 1997 covering 7825,216 inhabitants, i.e. 76% of CZpopulation, was used as the administrative data source. Also the overall expenditure, unit prices, and reimbursement criteria were analyzed. Results: Between 1997 and 2013 the utilization of statins rose from 2 to 96 DDD/TID while the ex

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FQ - Public health system, social medicine

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2015

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Health Policy

  • ISSN

    0168-8510

  • e-ISSN

  • Volume of the periodical

    119

  • Issue of the periodical within the volume

    9

  • Country of publishing house

    IE - IRELAND

  • Number of pages

    10

  • Pages from-to

    1255-1264

  • UT code for WoS article

    000361403000013

  • EID of the result in the Scopus database

    2-s2.0-84940614294